Registration assessment pass rate revealed

young pharmacist student looking at computer screen
skynesher / E+ via Getty Images

The pass rate for the registration assessment in November was 61.5%, the General Pharmaceutical Council (GPhC) and the Pharmaceutical Society of Northern Ireland (PSNI) have revealed.

Of the 1,174 trainee pharmacists who sat the registration assessment on 11 November, almost two thirds passed (61.5%). This was an increase of almost 4% compared to the Common Registration Assessment pass rate for autumn 2024 (58%) – held jointly by the GPhC and PSNI.

Related Article: Payment percentage for statutory branded medicines scheme drops to 16.5%

However, it was lower than the June 2025 sitting, where 77% of candidates passed the registration assessment.

There are two sittings of the assessment per year, one in the summer and one in the autumn.

For the November assessment, just over half (51%) of the trainee pharmacists were first time sitters, and 60% of them passed the exam. Meanwhile 68% of second time sitters and 47% of third time sitters also passed.

Related Article: Research review: a look at the latest clinical papers

Overall, 452 trainee pharmacists failed the exam. Guidance for unsuccessful trainees can be found on the GPhC website.

Successful trainees who have submitted their completed registration application and posted the required documents to the GPhC, will be added to the register on the next available registration date. The GPhC adds entries to the register on the 1st and 15th of every month.

Related Article: MenB vaccination programme to be rolled out in pharmacies

Chief standards officer at the GPhC, Lynsey Cleland, said: ‘Well done to all those who passed the assessment. It is the culmination of years of hard work, and we wish you a successful and fulfilling future in pharmacy. We look forward to you joining our register.

’For anyone who unfortunately did not pass the assessment at this sitting, there is information on our website on what options are available to you.’

Want news like this straight to your inbox?
Register for full access to the site and our bulletins
Have your say

Leave a Reply

Your email address will not be published. Required fields are marked *

Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.